Biobot Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
47
- Latest Deal Type
-
2ndary - Private
- Investors
-
14
Biobot General Information
Description
Developer of a robotic-assisted prostate intervention system designed to support prostate cancer diagnosis and treatment. The company develops a robotic platform that combines MRI-ultrasound image fusion, robotic needle positioning, and biopsy planning software for transperineal prostate biopsy and soft tissue ablation procedures, enabling healthcare providers to perform precise prostate interventions.
Contact Information
Website
www.biobotsurgical.comCorporate Office
- 79 Ayer Rajah Crescent
- Number 04-05
- Singapore, 139955
- Singapore
Corporate Office
- 79 Ayer Rajah Crescent
- Number 04-05
- Singapore, 139955
- Singapore
Biobot Timeline
Biobot Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Secondary Transaction - Private | 01-Jun-2026 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series C) | 09-Apr-2026 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 14-Apr-2025 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B) | 07-Mar-2024 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 26-Apr-2021 | Completed | Generating Revenue | |||
| 4. Seed Round | 17-Sep-2018 | Completed | Generating Revenue | |||
| 3. Seed Round | 29-Jun-2016 | Completed | Generating Revenue | |||
| 2. Seed Round | 01-Jan-2011 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Biobot Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A | ||||||||
| Seed | 7,446,935 | $0.51 | $0.51 | 1x | $0.51 | 15.08% | ||
| Seed | 1,678,803 | $0.52 | $0.52 | 1x | $0.52 | 3.4% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Biobot Patents
Biobot Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026235631-A1 | Method and system for generating a set of tool trajectories | Pending | 06-May-2025 | ||
| WO-2026206264-A1 | Method and system for deviation compensation | Pending | 28-Mar-2025 | ||
| WO-2026142501-A1 | Method and system for generating a biopsy plan | Pending | 24-Dec-2024 | ||
| AU-2024433589-A1 | A needle guidance system and method | Pending | 12-Mar-2024 | ||
| WO-2025193156-A1 | A needle guidance system and method | Pending | 12-Mar-2024 | A61B17/3403 |
Biobot Signals
Biobot Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| ClavystBio | Venture Capital | Minority | ||
| Kupa | Corporation | Minority | ||
| Angel (individual) | Minority | |||
| PTSM holding | Other | Minority |
Biobot Investments (1)
Biobot’s most recent deal was a Joint Venture with Shanghai Intbot Robotics. The deal was made on 21-Mar-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Shanghai Intbot Robotics | 21-Mar-2021 | Joint Venture | Machinery (B2B) |
Biobot FAQs
-
When was Biobot founded?
Biobot was founded in 2007.
-
Where is Biobot headquartered?
Biobot is headquartered in Singapore, Singapore.
-
What is the size of Biobot?
Biobot has 47 total employees.
-
What industry is Biobot in?
Biobot’s primary industry is Surgical Devices.
-
Is Biobot a private or public company?
Biobot is a Private company.
-
What is Biobot’s current revenue?
The current revenue for Biobot is .
-
How much funding has Biobot raised over time?
Biobot has raised $54.3M.
-
Who are Biobot’s investors?
, ClavystBio, Kupa, , and PTSM holding are 5 of 14 investors who have invested in Biobot.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process